0001683168-24-000240.txt : 20240111
0001683168-24-000240.hdr.sgml : 20240111
20240111193830
ACCESSION NUMBER: 0001683168-24-000240
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richieri Richard A.
CENTRAL INDEX KEY: 0001976193
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 24530329
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-01-09
0
0000704562
Avid Bioservices, Inc.
CDMO
0001976193
Richieri Richard A.
14191 MYFORD ROAD
TUSTIN
CA
92780
0
1
0
0
Chief Operations Officer
0
Common Stock, $0.001 par value
2024-01-09
4
M
0
507
A
24675
D
Common Stock, $0.001 par value
2024-01-09
4
M
0
945
A
25620
D
Common Stock, $0.001 par value
2024-01-09
4
M
0
1060
A
26680
D
Common Stock, $0.001 par value
2024-01-10
4
S
0
1055
6.17
D
25625
D
Common Stock, $0.001 par value
2024-01-09
4
M
0
40
A
5109
I
By Spouse
Common Stock, $0.001 par value
2024-01-09
4
M
0
83
A
5192
I
By Spouse
Common Stock, $0.001 par value
2024-01-09
4
M
0
132
A
5324
I
By Spouse
Common Stock, $0.001 par value
2024-01-10
4
S
0
116
6.17
D
5208
I
By Spouse
Restricted Stock Units
2024-01-09
4
M
0
507
0.0000
D
Common Stock
507
33385
D
Restricted Stock Units
2024-01-09
4
M
0
945
0.0000
D
Common Stock
945
32440
D
Restricted Stock Units
2024-01-09
4
M
0
1060
0.0000
D
Common Stock
1060
31380
D
Restricted Stock Units
2024-01-09
4
M
0
40
0.0000
D
Common Stock
40
3262
I
By Spouse
Restricted Stock Units
2024-01-09
4
M
0
83
0.0000
D
Common Stock
83
3179
I
By Spouse
Restricted Stock Units
2024-01-09
4
M
0
132
0.0000
D
Common Stock
132
3047
I
By Spouse
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Represents the shares automatically sold by the reporting person and/or the reporting person's spouse pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4, 5 and 6. This sale does not represent a discretionary trade.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $6.14 to $6.205. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
/s/ Stephen Hedberg, by Power of Attorney for Richard A. Richieri
2024-01-11